Methyl 7H-pyrrolo[2,3-d]pyrimidine-4-carboxylate is a heterocyclic organic compound characterized by its unique bicyclic structure, which incorporates both pyrrole and pyrimidine rings. This compound typically exhibits a range of chemical properties, including moderate solubility in polar organic solvents due to the presence of the carboxylate group. It may participate in various chemical reactions, such as nucleophilic substitutions and cycloadditions, owing to the reactivity of the pyrimidine moiety. The compound is of interest in medicinal chemistry, as derivatives of pyrrolo[2,3-d]pyrimidines have been studied for their potential biological activities, including anti-cancer and anti-inflammatory properties. Its molecular structure allows for potential interactions with biological targets, making it a candidate for further pharmacological exploration. Additionally, the presence of the methyl ester group can influence its lipophilicity and bioavailability. Overall, methyl 7H-pyrrolo[2,3-d]pyrimidine-4-carboxylate represents a significant scaffold in the development of novel therapeutic agents.

methyl 7H-pyrrolo[2,3-d]pyrimidine-4-carboxylate

1095822-17-5: Methyl 7H-pyrrolo[2,3-d]pyrimidine-4-carboxylate is a heterocyclic organic compound characterized by its unique bicyclic structure, which incorporates both pyrrole and pyrimidine rings. This compound typically exhibits a range of chemical properties, including moderate solubility in polar organic solvents due to the presence of the carboxylate group. It may participate in various chemical reactions, such as nucleophilic substitutions and cycloadditions, owing to the reactivity of the pyrimidine moiety. The compound is of interest in medicinal chemistry, as derivatives of pyrrolo[2,3-d]pyrimidines have been studied for their potential biological activities, including anti-cancer and anti-inflammatory properties. Its molecular structure allows for potential interactions with biological targets, making it a candidate for further pharmacological exploration. Additionally, the presence of the methyl ester group can influence its lipophilicity and bioavailability. Overall, methyl 7H-pyrrolo[2,3-d]pyrimidine-4-carboxylate represents a significant scaffold in the development of novel therapeutic agents.

CAS 1095822-17-5

methyl 7H-pyrrolo[2,3-d]pyrimidine-4-carboxylate

Methyl 7H-pyrrolo[2,3-d]pyrimidine-4-carboxylate

Ref: IN-DA0039XX

Methyl 7H-pyrrolo[2,3-d]pyrimidine-4-carboxylate

Ref: 54-OR317002

METHYL 7H-PYRROLO[2,3-D]PYRIMIDINE-4-CARBOXYLATE

Ref: 10-F389819